VSC.DE
Price:
$2.98
Market Cap:
$150.70M
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaborat...[Read more]
Industry
Biotechnology
IPO Date
2008-02-25
Stock Exchange
XETRA
Ticker
VSC.DE
According to 4SC AG’s latest financial reports and current stock price. The company's current PE Ratio is -7.27. This represents a change of 95.15% compared to the average of -3.72 of the last 4 quarters.
The mean historical PE Ratio of 4SC AG over the last ten years is -1.68. The current -7.27 PE Ratio has changed 43.07% with respect to the historical average. Over the past ten years (40 quarters), VSC.DE's PE Ratio was at its highest in in the June 2021 quarter at 8.04. The PE Ratio was at its lowest in in the September 2022 quarter at -4.99.
Average
-1.68
Median
-1.39
Minimum
-3.66
Maximum
-0.62
Discovering the peaks and valleys of 4SC AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 115.57%
Maximum Annual PE Ratio = -0.62
Minimum Annual Increase = -33.10%
Minimum Annual PE Ratio = -3.66
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -3.66 | 74.36% |
| 2022 | -2.10 | -33.10% |
| 2021 | -3.14 | 115.57% |
| 2020 | -1.46 | -0.47% |
| 2019 | -1.46 | 41.34% |
| 2018 | -1.03 | -22.47% |
| 2017 | -1.33 | 34.02% |
| 2016 | -1.00 | -4.18% |
| 2015 | -1.04 | 66.90% |
| 2014 | -0.62 | 9.13% |
The current PE Ratio of 4SC AG (VSC.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.96
5-year avg
-2.36
10-year avg
-1.68
4SC AG’s PE Ratio is less than InflaRx N.V. (-1.34), less than Haemato AG (13.61), less than ViewRay, Inc. (-0.04), less than Inovio Pharmaceuticals, Inc. (-0.00), less than Clovis Oncology, Inc. (-0.04), less than CytoTools AG (-0.01), less than Medigene AG (-0.10), less than co.don AG (-0.60), less than Core One Labs Inc. (-0.28), less than Aurora Cannabis Inc. (5.79),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.34 | $129.91M | |
| 13.61 | $111.50M | |
| -0.04 | $207.23M | |
| -0.00 | $12.56M | |
| -0.04 | $13.19M | |
| -0.01 | $164.40K | |
| -0.10 | $1.97M | |
| -0.60 | $6.55M | |
| -0.28 | $4.55M | |
| 5.79 | $19.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 4SC AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 4SC AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is 4SC AG's PE Ratio?
How is the PE Ratio calculated for 4SC AG (VSC.DE)?
What is the highest PE Ratio for 4SC AG (VSC.DE)?
What is the 3-year average PE Ratio for 4SC AG (VSC.DE)?
What is the 5-year average PE Ratio for 4SC AG (VSC.DE)?
How does the current PE Ratio for 4SC AG (VSC.DE) compare to its historical average?